Verona Pharma plc (Nasdaq: VRNA) to Ring The Nasdaq Stock Market Closing Bell
October 06 2017 - 10:00AM
What:Verona Pharma plc (Nasdaq:VRNA), a
clinical stage biopharmaceutical company focused on the development
and commercialization of innovative therapies for respiratory
diseases with high unmet medical need, will visit the Nasdaq
MarketSite in Times Square.
In May, the Company completed financing of $90 million through a
global offering comprising an IPO on the NASDAQ Global Market and a
concurrent European private placement, together with a shareholder
private placement. Verona Pharma was also recently awarded the 2017
Biotech and Money UK Life Science IPO of the Year Award, and named
as finalist for Scrip’s 2017 Financing of the Year Award.
In honor of the occasion, Jan-Anders Karlsson, Chief
Executive Officer and Executive Director, along with a
group of Verona Pharma colleagues, will ring the Closing
Bell.
Verona Pharma’s lead product candidate, RPL554, is a
first-in-class inhaled compound with both bronchodilator and
anti-inflammatory effects and is being investigated for the
treatment of chronic obstructive pulmonary disease and cystic
fibrosis, two debilitating respiratory diseases with significant
gaps in current treatment options for patients.
Where:Nasdaq MarketSite – 4 Times Square – 43rd
& Broadway – Broadcast Studio
When:Monday, October 9, 2017 – 3:45 p.m. to
4:00 p.m. ET
Nasdaq MarketSite:Emily Pan(646)
441-5120emily.pan@nasdaq.com
US Media and Investor Inquiries:ICR, Inc.James
Heins (media) / Stephanie Carrington (investors)203-682-8251 /
646-277-1282James.Heins@icrinc.com /
Stephanie.Carrington@icrinc.com
Feed Information:Fiber Line (Encompass
Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia features such as
exclusive content, photo postings, status updates and video of bell
ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our
Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our
YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our
Tumblr page:http://nasdaq.tumblr.com/
Webcast: A live stream of the Nasdaq Closing
Bell will be available at: https://new.livestream.com/nasdaq/live
or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of
the Market Close, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market close of your choice.
About Verona Pharma plcVerona Pharma is a
clinical-stage biopharmaceutical company focused on developing and
commercializing innovative therapeutics for the treatment of
respiratory diseases with significant unmet medical needs. Verona
Pharma's product candidate, RPL554, is a first-in-class, inhaled,
dual inhibitor of the enzymes phosphodiesterase 3 and 4 that acts
as both a bronchodilator and an anti-inflammatory agent in a single
compound. In clinical trials, treatment with RPL554 has been
observed to result in statistically significant improvements in
lung function as compared to placebo and has shown clinically
meaningful and statistically significant improvements in lung
function when added to two commonly used bronchodilators as
compared to either bronchodilator administered as a single agent.
Verona Pharma is developing RPL554 for the treatment of chronic
obstructive pulmonary disease (COPD), cystic fibrosis, and
potentially asthma.
About Nasdaq: Nasdaq (Nasdaq:NDAQ) is a leading
global provider of trading, clearing, exchange technology, listing,
information and public company services. Through its diverse
portfolio of solutions, Nasdaq enables customers to plan, optimize
and execute their business vision with confidence, using proven
technologies that provide transparency and insight for navigating
today's global capital markets. As the creator of the world's first
electronic stock market, its technology powers more than 90
marketplaces in 50 countries, and 1 in 10 of the world's securities
transactions. Nasdaq is home to approximately 3,900 total listings
with a market value of approximately $12 trillion. To learn more,
visit: http://business.nasdaq.com.
-NDAQA-
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Apr 2023 to Apr 2024